Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA clarifies which device modifications will need a new 510(k) submission

This article was originally published in Clinica

Executive Summary

The US Food and Drug Administration has issued for comments a draft guideline that aims to better clarify which changes a manufacturer makes to an already marketed device will warrant the submission of a new pre-market notification, or 510(k), application.